>AT5G05620.1 |  GCP2 (GAMMA-TUBULIN COMPLEX PROTEIN 2) GTP binding / GTPase/ structural molecule 
MPREIITLQVGQCGNQIGMEFWKQLCLEHGISKDGILEDFATQGGDRKDVFFYQADDQHY 
IPRALLIDLEPRVINGIQNGEYRNLYNHENIFLSDHGGGAGNNWASGYHQGKGVEEEIMD 
MIDREADGSDSLEGFVLCHSIAGGTGSGMGSYLLETLNDRYSKKLVQTYSVFPNQMETSD 
VVVQPYNSLLTLKRLTLNADCVVVLDNTALNRIAVERLHLTNPTFAQTNSLVSTVMSAST 
TTLRYPGYMNNDLVGLLASLIPTPRCHFLMTGYTPLTVERQANVIRKTTVLDVMRRLLQT 
KNIMVSSYARNKEASQAKYISILNIIQGEVDPTQVHESLQRIRERKLVNFIDWGPASIQV 
ALSKKSPYVQTSHRVSGLMLASHTSIRHLFSRCLSQYDKLRKKQAFLDNYRKFPMFADND 
LSEFDESRDIIESLVDEYKACESPDYIKWGMEDPGQLMTGEGNASGVADPKLAF*
>AT2G35520.1 |  DAD2 (DEFENDER AGAINST CELL DEATH 2) 
MVKSTSKDAQDLFHSLHSAYTATPTNLKIIDLYVCFAVFTALIQVAYMALVGSFPFNSFL 
SGVLSCIGTAVLAVCLRIQVNKENKEFKDLAPERAFADFVLCNLVLHLVIINFLG*
>AT2G35520.1 |  DAD2 (DEFENDER AGAINST CELL DEATH 2) 
MVKSTSKDAQDLFHSLHSAYTATPTNLKIIDLYVCFAVFTALIQVAYMALVGSFPFNSFL 
SGVLSCIGTAVLAVCLRIQVNKENKEFKDLAPERAFADFVLCNLVLHLVIINFLG*
>AT2G35520.2 |  DAD2 (DEFENDER AGAINST CELL DEATH 2) 
MVKSTSKDAQDLFHSLHSAYTATPTNLKIIDLYVCFAVFTALIQQVAYMALVGSFPFNSF 
LSGVLSCIGTAVLAVCLRIQVNKENKEFKDLAPERAFADFVLCNLVLHLVIINFLG*
>AT2G35520.2 |  DAD2 (DEFENDER AGAINST CELL DEATH 2) 
MVKSTSKDAQDLFHSLHSAYTATPTNLKIIDLYVCFAVFTALIQQVAYMALVGSFPFNSF 
LSGVLSCIGTAVLAVCLRIQVNKENKEFKDLAPERAFADFVLCNLVLHLVIINFLG*
>AT1G32210.1 |  ATDAD1 (DEFENDER AGAINST APOPTOTIC DEATH 1) 
MVKSTSKDAQDLFRSLRSAYSATPTNLKIIDLYVVFAVFTALIQVVYMALVGSFPFNSFL 
SGVLSCIGTAVLAVCLRIQVNKENKEFKDLAPERAFADFVLCNLVLHLVIINFLG*
>AT4G17760.1 |  damaged DNA binding / exodeoxyribonuclease III 
MSSSSSPAIEPDTPDLICQLDNVQGMVDALTCVRWKRHQDALVELSEHGIVLIVEESGCL 
QAKVYLQRELFTKYEYGAQGRPRFGISLGLLVDCLNTFSSPGHSNTIEIKYPGPDMELLL 
KSVDTLNSCIYSEIRTRIPETVTWDYNFEQAGIAPLTFTVKSAALKEAIDDLEWPGSSVQ 
ISLQKEPPCVIFRGEGHGDLQIDFMYYANTDLLLAFHCDTEVSYGYKYKFLKATTANIPG 
NVVRENRGSKLTIGRGGMLKVQHLVSVSKALAPQVESAGYQPPSRIAYIEFFVKPEEPAD 
*
>AT4G17760.1 |  damaged DNA binding / exodeoxyribonuclease III 
MSSSSSPAIEPDTPDLICQLDNVQGMVDALTCVRWKRHQDALVELSEHGIVLIVEESGCL 
QAKVYLQRELFTKYEYGAQGRPRFGISLGLLVDCLNTFSSPGHSNTIEIKYPGPDMELLL 
KSVDTLNSCIYSEIRTRIPETVTWDYNFEQAGIAPLTFTVKSAALKEAIDDLEWPGSSVQ 
ISLQKEPPCVIFRGEGHGDLQIDFMYYANTDLLLAFHCDTEVSYGYKYKFLKATTANIPG 
NVVRENRGSKLTIGRGGMLKVQHLVSVSKALAPQVESAGYQPPSRIAYIEFFVKPEEPAD 
*
>AT4G17760.2 |  damaged DNA binding / exodeoxyribonuclease III 
METPPESGCLQAKVYLQRELFTKYEYGAQGRPRFGISLGLLVDCLNTFSSPGHSNTIEIK 
YPGPDMELLLKSVDTLNSCIYSEIRTRIPETVTWDYNFEQAGIAPLTFTVKSAALKEAID 
DLEWPGSSVQISLQKEPPCVIFRGEGHGDLQIDFMYYANTDLLLAFHCDTEVSYGYKYKF 
LKATTANIPGNVVRENRGSKLTIGRGGMLKVQHLVSVSKALAPQVESAGYQPPSRIAYIE 
FFVKPEEPAD*
>AT4G17760.2 |  damaged DNA binding / exodeoxyribonuclease III 
METPPESGCLQAKVYLQRELFTKYEYGAQGRPRFGISLGLLVDCLNTFSSPGHSNTIEIK 
YPGPDMELLLKSVDTLNSCIYSEIRTRIPETVTWDYNFEQAGIAPLTFTVKSAALKEAID 
DLEWPGSSVQISLQKEPPCVIFRGEGHGDLQIDFMYYANTDLLLAFHCDTEVSYGYKYKF 
LKATTANIPGNVVRENRGSKLTIGRGGMLKVQHLVSVSKALAPQVESAGYQPPSRIAYIE 
FFVKPEEPAD*